Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
The Lancet

How to test for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directions

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...
The LancetOpinion

More equitable preconception health: paternal life course opportunities for better pregnancy, child, and family outcomes

Men and partners are important contributors to the health of future generations, yet their own preconception health and ...
wvgazettemail.com

FBI: Violent crime down in WV, but violent offenses on child victims increasing

Recent crime data shows violent crime overall declining in West Virginia, but a growing percentage of victims are children, ...
Scientific Research Publishing

Body Image and Stigma Experiences among Patients with Lower Limb Lymphedema Secondary to Genital Neoplasms, Female Surgery: A Qualitative Study ()

Body Image and Stigma Experiences among Secondary to Genital Neoplasms, Female Surgery: A Qualitative Study Objective: To ...
ahajournals.org

Clinical Guidelines as a Continuous Work in Progress: Moving at the Speed of Science

VESALIUS-CV is a large (N=12 257), rigorously conducted, international, randomized, placebo-controlled trial conducted in patients at high cardiovascular risk but without prior myocardial infarction ...